Details of the Drug

General Information of Drug (ID: DMUISAW)

Drug Name
RG6411
Indication
Disease Entry ICD 11 Status REF
Aggressive cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD ID
D2UB6Z

References

1 Clinical pipeline report, company report or official report of Roche